Treatment of poppy seed tea misuse with buprenorphine in a telehealth practice: a case series

References

• Gu JK, Allison P, Grimes Trotter A, Charles LE, Ma CC, Groenewold M, Andrew ME, Luckhaupt SE. Prevalence of self-reported prescription opioid use and illicit drug use among U.S. adults: NHANES 2005–2016. J Occup Environ Med. 2022;64(1):39–45. doi:10.1097/JOM.0000000000002328.
   PubMed Web of Science ®Google Scholar
• Haber I, Pergolizzi J, Jr, LeQuang JA. Poppy seed tea: a short review and case study. Pain Ther. 2019;8(1):151–5. doi:10.1007/s40122-019-0113-5.
   PubMed Web of Science ®Google Scholar
• The Observatory of Economic Complexity. Poppy seeds. Available at: https://oec.world/en/profile/hs/poppy-seeds. Accessed August 17, 2023.
   Google Scholar
• Powers D, Erickson S, Swortwood MJ. Quantification of morphine, codeine, and thebaine in home-brewed poppy seed tea by LC-MS/MS. J Forensic Sci. 2018;63(4):1229–35. doi:10.1111/1556-4029.13664.
   PubMed Web of Science ®Google Scholar
• Knutsen HK, Alexander J, Barregård L, Bignami M, Brüschweiler B, Ceccatelli S, Cottrill B, Dinovi M, Edler L, Grasl-Kraupp B, et al. Update of the Scientific Opinion on opium alkaloids in poppy seeds. EFSA J. 2018;16(5):e05243.
   PubMed Web of Science ®Google Scholar
• Kauppila GR, Eagen KV. Opioid use disorder from poppy seed tea use: a case report. Am J Case Rep. 2023;24:e938675. Published 2023 Jan 26. doi:10.12659/AJCR.938675.
   PubMed Web of Science ®Google Scholar
• Greenthal E, Lurie P, Doyon S. Opioid exposure associated with poppy consumption reported to poison control centers and the U.S. Food and Drug Administration. Clin Toxicol (Phila). 2021;59(8):746–55. doi:10.1080/15563650.2020.1866766.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Justice. Drug Alert Watch: opium Tea. March 2, 2010; Available at: https://www.justice.gov/archive/ndic/pubs40/40404/sw-Opium_Tea.pdf. Accessed August 17, 2023.
   Google Scholar
• Lloyd-Jones DM, Bonomo Y. Unusual presentations for pharmacotherapy-poppy seed dependence. Drug Alcohol Rev. 2006;25(4):375–6. doi:10.1080/09595230600741370.
   PubMed Web of Science ®Google Scholar
• Unnithan S, Strang J. Poppy tea dependence. Br J Psychiatry. 1993;163(6):813–4. doi:10.1192/bjp.163.6.813.
   PubMedGoogle Scholar
• Hagan S, Achtmeyer CE, Hood C, Hawkins EJ, Williams EC. Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report. Addict Sci Clin Pract. 2021;16(1):71. doi:10.1186/s13722-021-00280-4.
   PubMed Web of Science ®Google Scholar
• Nanjayya SB, Murthy P, Chand PK, Kandaswamy A, Nikketha BS, Benegal V, Shivappa M. A case of poppy tea dependence in an octogenarian lady. Drug Alcohol Rev. 2010;29(2):216–8. doi:10.1111/j.1465-3362.2009.00134.x.
   PubMed Web of Science ®Google Scholar
• King MA, McDonough MA, Drummer OH, Berkovic SF. Poppy tea and the baker’s first seizure [published correction appears in Lancet 1997 Oct 18;350(9085):1182]. Lancet. 1997;350(9079):716. doi:10.1016/S0140-6736(05)63516-7.
   PubMedGoogle Scholar
• Rollston R, Gallogly W, Hoffman L, Tewari E, Powers S, Clear B. Collaborative, patient-centred care model that provides tech-enabled treatment of opioid use disorder via telehealth. BMJ Innov. 2022;8(2):117–22. doi:10.1136/bmjinnov-2021-000816.
   Google Scholar
• Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A. Initiating opioid use disorder medication via telemedicine during COVID-19: implications for proposed reforms to the Ryan Haight Act. J Gen Intern Med. 2022;37(1):162–7. doi:10.1007/s11606-021-07174-w.
   PubMed Web of Science ®Google Scholar
• Warner ML, Kaufman NC, Grundmann O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. Int J Legal Med. 2016;130(1):127–38. doi:10.1007/s00414-015-1279-y.
   PubMed Web of Science ®Google Scholar
• Bin Abdullah MFIL. Kratom dependence and treatment options: a comprehensive review of the literature. Curr Drug Targets. 2020;21(15):1566–79. doi:10.2174/1389450121666200719011653.
   PubMed Web of Science ®Google Scholar
• Schimmel J, Amioka E, Rockhill K, Haynes CM, Black JC, Dart RC, Iwanicki JL. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction. 2021;116(1):176–81. doi:10.1111/add.15082.
   PubMed Web of Science ®Google Scholar
• Ellis MS, Buttram ME, Forber A, Black JC. Associations between kratom-related state policy environments and kratom use in a nationally representative population in the United States [published online ahead of print, 2023 Jun 12]. J Psychoactive Drugs. 2023;1–9. doi:10.1080/02791072.2023.2223622.
   PubMed Web of Science ®Google Scholar
• Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103(6):1048–50. doi:10.1111/j.1360-0443.2008.02209.x.
   PubMed Web of Science ®Google Scholar
• Weiss ST, Douglas HE. Treatment of Kratom withdrawal and dependence with buprenorphine/naloxone: a case series and systematic literature review. J Addict Med. 2021;15(2):167–72. doi:10.1097/ADM.0000000000000721.
   PubMed Web of Science ®Google Scholar
• Alabama Senate Bill 272 of 2022. Available at: https://arc-sos.state.al.us/ucp/L0929893.AI1.pdf. Accessed August 17, 2023.
   Google Scholar
• Broyan VR, Brar JK, Allgaier Student T, Allgaier JT. Long-term buprenorphine treatment for kratom use disorder: a case series. Subst Abus. 2022;43(1):763–6. doi:10.1080/08897077.2021.2010250.
   PubMed Web of Science ®Google Scholar
• London M, O’Regan T, Aust P, Stockford A. Poppy tea drinking in East Anglia. Br J Addict. 1990;85(10):1345–7. doi:10.1111/j.1360-0443.1990.tb01611.x.
   PubMedGoogle Scholar
• Braye K, Harwood T, Inder R, Beasley R, Robinson G. Poppy seed tea and opiate abuse in New Zealand. Drug Alcohol Rev. 2007;26(2):215–9. doi:10.1080/09595230601146637.
   PubMed Web of Science ®Google Scholar